Resources from the same session
3307 - Switch Maintenance Gemcitabine After First Line Chemotherapy In Patients With Malignant Mesothelioma; A Multicenter Open Label Phase II Trial (NVALT19)
Presenter: Sjaak Burgers
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies - Invited Discussant 1740PD, 1741PD, 1742PD and LBA92
Presenter: Giuseppe Lo Russo
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast